Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients - UFR SVE Sciences de la vie et de l'environnement Accéder directement au contenu
Poster De Conférence Année : 2022

Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients

Résumé

Meeting Abstract PM2-014
Fichier non déposé

Dates et versions

hal-03713911 , version 1 (05-07-2022)

Identifiants

  • HAL Id : hal-03713911 , version 1

Citer

D. Fournier, S. Jouneau, G. Bouzille, E. Polard, M. N. Osmont, et al.. Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients. Annual Meeting of French Society of Pharmacology and Therapeutics, Jun 2022, Lille, France. 36, pp.77-78, 2022. ⟨hal-03713911⟩
14 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More